BioMed Linkage Tech Co., Ltd.
BioMed Linkage offers comprehensive, one-stop solutions for CRO and CDMO services in China. We collaborate with top-tier CDMOs, pharmacology CROs, and GLP-certified CROs to provide end-to-end support across drug manufacturing, pharmacology, DMPK, and toxicology studies—spanning both IND- and NDA-enabling programs.
We bring particular strengths in two key areas:
1. IND and NDA-Enabling Studies
We specialize in DMPK and toxicology studies across multiple species, including non-human primates (NHPs), to support regulatory submissions from IND through NDA.
2. Extensive NHP Capabilities in China
Our robust resources allow us to support a wide range of NHP studies, including:
• Disease models for efficacy evaluation
• PK and efficacy studies using both naïve and non-naïve NHPs
• Pre-tox and formal toxicology studies for IND/NDA-enabling programs
With an experienced, China-based project management team, we ensure high-quality execution and strict adherence to timelines.
If you're seeking reliable and cost-effective CRO or CDMO services in China, BioMed Linkage is well positioned to be your trusted partner.
Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Appointment Request
Blocked Timeslot
Restricted Timeslot
Copyright © American College of Toxicology. All rights reserved.
You may view the ACT Privacy Policy, Code of Conduct, provide consent to ACT
to email you communications, or unsubscribe to stop receiving further ACT communication.
Privacy Policy | Code of Conduct | Provide Consent | Unsubscribe